v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net loss $ (18,726) $ (36,034)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,682 3,301
Stock-based compensation 10,738 10,416
Provision for credit losses and inventory 936 1,754
Amortization of operating lease right-of-use assets 697 572
Amortization of debt discount and issuance costs 765 610
Deferred income taxes (589) 15
Revaluation of contingent royalty obligation payable to Evolus Founders 1,236 (1,763)
Other adjustments to operating activities 304 480
Changes in operating assets and liabilities:    
Inventories 5,048 (4,291)
Accounts receivable (8,787) (1,781)
Prepaid expenses (708) (1,443)
Accounts payable (4,980) 3,945
Accrued expenses 2,497 (12,835)
Operating lease liabilities (840) (256)
Other operating assets (5,812) (3,113)
Net cash used in operating activities (13,539) (40,423)
Cash flows from investing activities    
Purchases of property and equipment (465) (1,007)
Additions to capitalized software (1,726) (3,121)
Net cash used in investing activities (2,191) (4,128)
Cash flows from financing activities    
Payment of contingent royalty obligation to Evolus Founders (2,442) (4,416)
Proceeds from issuance and modification of debt instruments 10,000 25,000
Payments for debt issuance costs (609) (2,610)
Issuance of common stock in connection with incentive equity plan 313 1,065
Payment of finance lease obligations (8) (7)
Net cash provided by financing activities 7,254 19,032
Effect of exchange rates on cash and cash equivalents (180) 305
Net decrease in cash and cash equivalents (8,656) (25,214)
Cash and cash equivalents, beginning of period 53,826 86,952
Cash and cash equivalents, end of period 45,170 61,738
Supplemental disclosure of cash flow information    
Cash paid for interest 3,546 7,786
Cash paid for income taxes 230 317
Non-cash investing and financing information    
Capital expenditures included in accounts payable and accrued expenses $ 499 $ 375